Skip to the page

Data / Form D filings / Persevere Therapeutics Inc.

Persevere Therapeutics Inc.: Form D filing

Persevere Therapeutics Inc., a company in Chesterbrook, PA, filed a Form D with the SEC in 2026. The latest, on March 4, 2026, reports $1.6 million sold of a $5 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
851 DUPORTAIL ROAD, 2ND FLOOR, Chesterbrook, PA, 19087
Phone
(610) 780-0622
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2115419

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 4, 2026New notice$4,999,999$1,574,999$3,425,00012Feb 11, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Greg BoschExecutive Officer, Director

Other companies in Pennsylvania that filed recently

Every Form D from the week of Mar 2, 2026 · All recent filings in Pennsylvania · All recent Other filings

Read from SEC EDGAR. Amount sold is what Persevere Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.